| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |